Dr. Julie A. Margenthaler MD
Oncologist | Medical Oncology660 South Euclid Avenue Campus Box 8109 St. Louis Missouri, 63110
Julie A. Margenthaler, MD, FACS, works at Washington University St. Louis in St. Louis, Missouri. An Associate Professor at the University, Dr. Margenthaler specializes in breast oncology, particularly breast cancer in those younger than 40. Author of over 20 journal articles on this topic and more, Dr. Margenthaler also serves Barnes Jewish Hospital and their affiliates.
Education and Training
Southern Illinois University School of Medicine
Southern Il Univ Sch Of Med- Springfield Il 1997
SurgeryAmerican Board of SurgeryABS
Expert PublicationsData provided by the National Library of Medicine
- The resistance of P. acnes--primed interferon gamma-deficient mice to low-dose lipopolysaccharide-induced acute liver injury.
- CD1-dependent natural killer (NK1.1(+)) T cells are required for oral and portal venous tolerance induction.
- Transfer of "infectious" cardiac allograft tolerance induced by donor-specific transfusion.
- Mechanism of portal venous tolerant long-term MHC Class I L(d)-specific skin graft survival in transgenic 2CF1 mice.
- Development of infectious tolerance after donor-specific transfusion and rat
- Donor-specific renal, but not cardiac, allograft tolerance promotes engraftment of the normally rejected rat skin graft.
- Donor-specific antigen transfusion-mediated skin-graft tolerance results from the peripheral deletion of donor-reactive CD8+ T cells.
- Effects of endotoxin tolerance on Propionibacterium acnes-primed lipopolysaccharide hepatic injury.
- "Infectious tolerance" develops after the spontaneous acceptance of Lewis-to-Dark Agouti rat liver transplants.
- Peripheral tolerance in transgenic mice expressing class I MHC L(d) only on cardiac cells.
- Oral and portal venous tolerance in the interferon-gamma knockout (GKO) mouse.
- The immunologic function of 1B2+ double negative (CD4-CD8-) T cells in the 2C
- Regional oral tolerance in transgenic 2C mice.
- Surgical removal of the primary tumor increases overall survival in patients with metastatic breast cancer: analysis of the 1988-2003 SEER data.
- Metastatic disease to the breast: the Washington University experience.
- Neoantigen DNA Vaccine Alone vs. Neoantigen DNA Vaccine Plus Durvalumab in Triple Negative Breast Cancer Patients Following Standard of Care Therapy
- PECS Block vs. Multimodal Analgesia for Prevention of Persistent Postoperative Pain in Breast Surgery
- Compare Outcomes Between Two Acellular Dermal Matrices
- LS301 Uptake in Tumors of Patients Undergoing Partial Mastectomy and Sentinel Lymph Node Biopsy for Breast Cancer
- Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score
- Safety and Immune Response to a Mammaglobin-A DNA Vaccine In Breast Cancer Patients Undergoing Neoadjuvant Endocrine Therapy
- Neoadjuvant Treatment of Triple Negative Breast Cancer Patients With Docetaxel and Carboplatin to Assess Anti-tumor Activity
- PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer
- Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
Areas of expertise and specialization
- James Ewing Foundation grant, Society of Surgical Oncology (2006-2007)
- 2006-2007 James Ewing Foundation grant, Society of Surgical Oncology
- 2000-2002 SUS/Ethicon Research Award
- 2000-2001 ALF Postdoctoral Fellowship Award
- 2004 Resident Teaching Award
- Breast Cancer, Breast Surgery, Breast Issues
- Research, Washington University School of Medicine, St. Louis MO 2002
- Breast Disease, Washington University School of Medicine, St. Louis MO 2006
- Washington University School of Medicine (Breast disease)
Professional Society Memberships
- American Medical Association, Association of Woman Surgeons, American Society of Clinical Oncology, American Society of Breast Surgeons, St. Louis Surgical Society
What do you attribute your success to?
- Having the Best Training and Working at a Facility with Terrific Treatment Centers and Resources
Hobbies / Sports
- Boating, Baseball, Live Music, Travel
Favorite professional publications
- Journal of Clinical Oncology, Annals of Surgical Oncology
Dr. Julie A. Margenthaler MD's Practice location
St. Louis, Missouri 63110Get Direction
Saint Louis, MO 63110Get Direction
Dr. Julie A. Margenthaler MD's reviewsWrite Review
Patient Experience with Dr. Margenthaler
- Leukopenia: Symptoms, Causes, and Treatment
What is leukopenia?White blood cells (WBCs) are an important part of the immune system, which is why they are called as "fighter cells". There are five different types of white blood cells (WBCs) in our body. They are neutrophils, eosinophils, basophils, monocytes, and lymphocytes. Each type of WBC...
- The Importance of Mentorship in Breast Cancer
Mentorship has been used for centuries for a variety of reasons, from training people in various work trades, to helping university students adjust, and helping people undergoing unique and complex situations cope. With a breast cancer diagnosis, mentoring has been a bright light in the darkness for...
- How Is Liver Cancer Diagnosed?
How is Liver Cancer Diagnosed?Liver cancer is a common type of cancer which begins in the liver cells, or hepatocytes. Liver cancer is a cancer which affects one of the largest and most important organs of the body. Liver cancer is type of cancer which, when diagnosed at early stages, can be...
- High-school Student Works Toward Major Breast Cancer Breakthrough
Many high school science projects aren’t exactly medical breakthroughs. They are streaming volcanoes filled with baking soda and soda, or maybe adorable plants growing in different types of soil. High school science fairs are meant to be fun and engaging, so that young boys and girls can be...
- Prostate Cancer: What Are the Symptoms If It Is Not Asymptomatic?
Prostate cancer tends to affect only men. The incidence of prostate cancer is on the increase and tends to be more common in the western world. The causes of prostate cancer are poorly understood. However, risks factors include a positive family history, environmental and dietary factors. The...
- New Diagnostic Tool Approved for Lymphoma
A new diagnostic tool has been approved by the U.S. Food and Drug Administration (FDA) to help researchers identify leukemia and lymphoma cells by using a technique known as flow cytometry. A flow cytometry test for non-Hodgkin’s lymphoma (NHL) can help determine whether normal or abnormal DNA is...
- Dr. Carl Freter MD3655 Vista Ave St Louis MO 63110
- Dr. Elaine Majerus MD1 Barnes Jewish Hospital Plz Saint Louis MO 63110
- Dr. Alaa A. Elbendary M.D.11652 Studt Ave Saint Louis MO 63141
- Dr. Steven Mark Sorscher MD4921 Parkview Pl Saint Louis MO 63110
- Dr. Russell K Pachynski MD4921 PARKVIEW PL SAINT LOUIS MO 63110
- Mateusz Opyrchal MD PHD4921 PARKVIEW PL SAINT LOUIS MO 63110